Labyrinthitis (Otitis Interna)

01/01/2004 - "The objective of this review was to assess the effects of local and/or systemic antibiotics for preventing complications such as postoperative discharge, graft failure and labyrinthitis in patients undergoing clean or clean-contaminated ear surgery. "
04/27/1977 - "In those days before the Antibiotic Era the indication to function-destructing radical surgery was justified in cases of suppurative labyrinthitis. "
10/01/1960 - "[On the prognosis of infectious labyrinthitis under the influence of antibiotics]."
05/01/1961 - "[The surgical therapy of purulent labyrinthitis in the antibiotic era]."
01/01/2004 - "There is no strong evidence that the large scale use of prophylactic of antibiotics in clean and clean-contaminated ear surgery is helpful in reducing postoperative complications such as wound infection, discharge from the outer ear canal, labyrinthitis and graft failure."

05/01/1999 - "To establish the therapeutic efficacy of acyclovir (Zovirax) and prednisolone in experimental HSV-1 viral labyrinthitis, we induced HSV-1 labyrinthitis in 12 guinea pigs. "
09/01/2022 - "To evaluate the efficacy of mixed oral prednisolone and intratympanic dexamethasone (ITID) injection in labyrinthitis, due to COVID 19. "

09/01/1995 - "It is concluded that ceftazidime should be a very useful agent in the treatment of bacterial labyrinthitis caused by susceptible organisms."
01/01/1996 - "Keeping in mind that the choice of drug for the treatment of suppurative labyrinthitis should be based foremost on culture and sensitivity studies, we consider ceftazidime to be the first-line agent for treatment and prevention of both meningogenic labyrinthitis and labyrinthitis complicating acute or chronic otitis media."

01/01/2023 - "Twin A received a 6-week course of penicillin, whereas twin B received 6 weeks plus an additional 10 days due to persistent left cochlear enhancement consistent with labyrinthitis. "
10/29/1950 - "[Labyrinthitis and penicillin]."
09/19/1951 - "[Acute destructive labyrinthitis; case with penicillin therapy]."
01/01/1946 - "Otocytic meningitis with pneumococcus mucosus following a labyrinthitis treated with penicillin, then with sulfonamides; healing."
02/01/1948 - "A case of labyrinthitis in early mastoiditis, cured by mastoidectomy and combined penicillin-sulfadiazine therapy."

02/01/2001 - "Preventing labyrinthitis ossificans: the role of steroids."
02/01/2001 - "All 4 patients who failed to receive steroid therapy developed labyrinthitis ossificans. "
02/01/2001 - "One of the 6 patients who received steroid therapy at the time of initial illness had documented evidence of labyrinthitis ossificans either radiographically or at the time of surgery. "
02/01/2001 - "The results of this retrospective study are highly suggestive of a role for steroids in preventing the development of labyrinthitis ossificans in children with pneumococcal meningitis."
02/01/2001 - "To identify a possible relationship between the administration of steroids at the time of diagnosis of bacterial meningitis and the development of labyrinthitis ossificans. "

09/01/2008 - "Tumor necrosis factor alpha is sufficient to recruit inflammatory cells to the cochlea but is not likely to be directly responsible for the hearing loss that follows immune-mediated labyrinthitis."
09/01/2008 - "Competitive inhibition of TNF-alpha receptors reduces inflammation and hearing loss in experimentally induced labyrinthitis in guinea pigs and mice. "
07/01/2006 - "TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis."
07/01/2006 - "The efficacy of etanercept (anti-TNFalpha) was evaluated in a guinea pig model of experimental autoimmune labyrinthitis in which 25 guinea pigs were divided in a control group, which was used to document the rise in hearing thresholds following immunisation, and two experimental groups, which were treated with steroids (6-methylprednisolone) and anti-TNFalpha (etanercept), respectively, after the immunisation. "
07/01/2006 - "The effectiveness of etanercept [tumour necrosis factor-alpha (TNFalpha) blocker] and corticoids in treating immuno-mediated inner ear disease (IMIED) was compared in an animal model of autoimmune labyrinthitis. "

01/01/2003 - "Etanercept will be able to reduce the inflammation and hearing loss associated with experimentally induced labyrinthitis. "
07/01/2006 - "We therefore conclude that etanercept is as effective as glucocorticoids in an animal model of autoimmune labyrinthitis; however, the potential adverse effects and high price of the former advise against its use as an initial therapy for IMIED."
07/01/2006 - "The efficacy of etanercept (anti-TNFalpha) was evaluated in a guinea pig model of experimental autoimmune labyrinthitis in which 25 guinea pigs were divided in a control group, which was used to document the rise in hearing thresholds following immunisation, and two experimental groups, which were treated with steroids (6-methylprednisolone) and anti-TNFalpha (etanercept), respectively, after the immunisation. "
07/01/2006 - "The effectiveness of etanercept [tumour necrosis factor-alpha (TNFalpha) blocker] and corticoids in treating immuno-mediated inner ear disease (IMIED) was compared in an animal model of autoimmune labyrinthitis. "

05/20/1967 - "Tetracycline as a cure for rolling disease (labyrinthitis) in laboratory rats."

02/01/1948 - "A case of labyrinthitis in early mastoiditis, cured by mastoidectomy and combined penicillin-sulfadiazine therapy."

07/01/2006 - "We therefore conclude that etanercept is as effective as glucocorticoids in an animal model of autoimmune labyrinthitis; however, the potential adverse effects and high price of the former advise against its use as an initial therapy for IMIED."
07/01/2006 - "TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis."

08/01/2021 - "Our patient was successfully treated as an outpatient without unnecessary investigations and responded well to standard therapy for viral labyrinthitis as per National Health Service (NHS) guidelines. "
07/01/1956 - "[Problem of diagnosis and therapy of labyrinthitis]."
01/01/1952 - "[Clinical aspects and therapy of labyrinthitis]."
01/01/2007 - "In cases of suppurative labyrinthitis or reparative granuloma extending into the vestibule, prognosis is usually poor, despite aggressive medical therapy or revision surgery. "
02/01/2001 - "All 4 patients who failed to receive steroid therapy developed labyrinthitis ossificans. "

07/01/2014 - "The incidence of tympanogenic labyrinthitis ossification in patients who had undergone a mastoidectomy was 2 per cent."
02/01/1968 - "Acute mastoiditis and acute labyrinthitis without mastoidectomy."
01/01/2010 - "Urgent mastoidectomy was indicated for 4 intracranial complications (3 meningitis and 1 brain abscess) and 14 extracranial complications of acute/COM or MOE (7 patients with labyrinthitis and 7 patients with facial nerve, FN, paralysis). "
12/01/1949 - "Modified technic of plastic procedure in radical mastoidectomy; report of results in a case of circumscribed labyrinthitis and periphlebitis of the lateral sinus in the course of chronic purulent otitis media with cholesteatoma."
02/01/1948 - "A case of labyrinthitis in early mastoiditis, cured by mastoidectomy and combined penicillin-sulfadiazine therapy."

01/01/2023 - "To report the experience of an image-guided and navigation-based robot arm as an assistive surgical tool for cochlear implantation in a case with a labyrinthitis ossificans. "
11/01/2022 - "Successful cochlear implantation in the setting of labyrinthitis ossificans is challenging. "
10/01/2019 - "Human otopathology following drill-out procedures for cochlear implantation (CI) in cases with labyrinthitis ossificans (LO) has not been previously described. "
04/01/2019 - "In rare cases, PAN may be associated with progressive labyrinthitis ossificans (LO), an otologic emergency requiring early cochlear implantation (CI) to restore hearing before the complete, irreversible cochlear ossification. "
12/01/2018 - "Facial Nerve Stimulation Patterns Associated With Cochlear Implantation in Labyrinthitis Ossificans."

11/01/2022 - "While reverse programming is often recommended in the case of retrograde electrode insertion, we present our experience of retrograde electrode insertion for labyrinthitis ossificans, where standard programming was adopted due to patient preference and provided satisfactory outcomes."
11/01/2022 - "Standard Programming of Retrograde Electrode Insertion via Middle-Turn Cochleostomy in Labyrinthitis Ossificans."
11/01/2021 - "The presence of labyrinthitis ossificans or the limited extent of electrode insertion produced overall results that were comparable with other cases."
11/01/2021 - "Twenty-seven (52%) patients had some degree of labyrinthitis ossificans and 19 of them had full electrode insertion via basal turn cochleostomy. "
01/01/2000 - "Compressed electrode arrays in cases of obliterative labyrinthitis ossificans."

04/15/2022 - "MRI revealed faint early ossification/possible labyrinthitis ossificans of the basal cochlea, which was confirmed on surgical exploration during the placement of cochlear implants bilaterally 42 days later. "
02/05/2020 - "Evolution of Cochlear implant mapping and vestibular function in a pediatric case of Labyrinthitis."
12/01/2017 - "Cochlear Implant Associated Labyrinthitis: A Previously Unrecognized Phenomenon With a Distinct Clinical and Electrophysiological Impedance Pattern."
12/01/2003 - "Case report: explantation of a cochlear implant secondary to chronic granulating labyrinthitis."
10/01/2000 - "Labyrinthitis ossificans is a recently recognized entity with the extending cochlear implant surgery. "